TOKYO -- Expectations are rising about the availability of COVID-19 vaccines, as the U.S. announced on Friday it had approved emergency use of one developed by Pfizer and German partner BioNTech.
Pfizer inoculations proceed in West while other countries to wait months
A sign directs health care workers to a practice session for administering the Pfizer COVID-19 vaccine. © Reuters
TOKYO -- Expectations are rising about the availability of COVID-19 vaccines, as the U.S. announced on Friday it had approved emergency use of one developed by Pfizer and German partner BioNTech.